Thrivent Financial for Lutherans
HIV

Thrivent Financial for Lutherans’s CALYPTE BIOMEDICAL CORP NEW HIV Stock Holding History

Thrivent Financial for Lutherans’s Portfolio HIV Stock Details HIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-40,000
Closed – – 2431
2017
Q3 		$0 Buy
+40,000
New – ﹤0.01% 2503